科研之友
微信
新浪微博
Facebook
分享链接
摘要
Introduction
Neurodegeneration and neurofibrillary degeneration in Alzheimer's disease brains
Dysfunction of protein synthesis mediated by mTOR-dependent signalling in Alzheimer's disease brains
Neurodegeneration mediated by mTOR-dependent signalling
Tau phosphorylation mediated by mTOR-dependent signalling
mTOR-dependent signalling in lymphocytes of AD: potential biomarkers for AD diagnosis
mTOR-dependent signalling and other neurodegenerative diseases
Perspectives
Conclusions
Neurodegeneration and neurofibrillary degeneration are the two main pathological mechanisms of cognitive impairments in Alzheimer's disease (AD). It is not clear what factors determine the fates of neurons during the progress of the disease. Emerging evidence has suggested that mTOR-dependent signalling is involved in the two types of degeneration in AD brains. This review focuses on the roles of mTOR-dependent signalling in the pathogenesis of AD. It summarizes the recent advancements in the understanding of its roles in neu-rodegeneration and neurofibrillary degeneration, as well as the evidence achieved when mTOR-related signalling components were tested as potential biomarkers of cognitive impairments in the clinical diagnosis of AD.
- 出版日期2008-12
